Health Care & Life Sciences » Biotechnology | Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
771,750.10
815,864.40
889,766.30
886,959.30
911,268.40
1,027
Cost of Goods Sold (COGS) incl. D&A
460,103.20
472,822.00
459,814.50
439,719.10
425,956.10
437
Gross Income
311,646.90
343,042.40
429,951.90
447,240.20
485,312.40
590
SG&A Expense
244,788.50
258,996.60
364,344.30
344,185.70
396,949.00
512
EBIT
57,576.00
77,424.70
56,864.70
104,794.30
74,349.90
116
Unusual Expense
12.60
13.80
2,464.50
-
-
-
Non Operating Income/Expense
4,318.90
7,629.20
4,195.10
2,654.70
3,338.20
43
Interest Expense
9,695.00
13,942.00
12,780.10
4,540.50
3,723.30
2
Pretax Income
54,970.50
75,991.30
57,078.10
105,939.30
81,094.30
80
Income Tax
4,327.70
20,053.40
18,250.60
20,858.60
17,179.80
20
Consolidated Net Income
59,298.20
55,937.90
38,827.50
85,080.70
63,914.50
60
Net Income
45,238.90
41,750.50
25,970.90
73,250.50
57,950.70
57
Net Income After Extraordinaries
45,238.90
41,750.50
25,970.90
73,250.50
57,950.70
57
Net Income Available to Common
45,238.90
41,750.50
25,970.90
73,250.50
57,950.70
57
EPS (Basic)
0.03
0.02
0.02
0.04
0.03
0.03
Basic Shares Outstanding
1,678,000.00
1,678,000.00
1,678,000.00
1,678,000.00
1,678,000.00
1,678
EPS (Diluted)
0.03
0.02
0.02
0.04
0.03
0.03
Diluted Shares Outstanding
1,678,000.00
1,678,000.00
1,678,000.00
1,678,000.00
1,678,000.00
1,678
EBITDA
87,569.60
106,625.10
85,657.80
127,837.80
94,555.40
138
Other Operating Expense
9,282.50
6,621.10
8,742.90
1,739.80
14,013.50
38
Non-Operating Interest Income
2,758.10
4,865.50
6,333.90
3,030.90
5,653.60
9
Minority Interest Expense
14,059.30
14,187.40
12,856.60
11,830.20
5,963.80
4

About Shenzhen Neptunus Interlong Bio-Technique Co.

View Profile
Address
18th Floor, United Centre
Hong Kong
Hong Kong
Employees -
Website http://www.interlong.com
Updated 07/08/2019
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines and healthcare food products. It operates through the following segments: Manufacturing and Selling of Medicines; Sales and Distribution of Medicines and Healthcare Products; and Provision of Research and Development Services of Modern Biological Technology. The company was founded on November 15, 1994 and is headquartered in Hong Kong.